Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101.
about
Markers of Response to Antiangiogenic Therapies in Colorectal Cancer: Where Are We Now and What Should Be Next?A review of the past, present, and future directions of neoplasiaComing of Age in the Life ofNeoplasia: Where We Have Been and Where We Are GoingThe Theranostic Path to Personalized NanomedicineNon-invasive imaging for studying anti-angiogenic therapy effects.DCE@urLAB: a dynamic contrast-enhanced MRI pharmacokinetic analysis tool for preclinical data.Dynamic contrast-enhanced magnetic resonance imaging: fundamentals and application to the evaluation of the peripheral perfusionDynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478.Correlation of MRI biomarkers with tumor necrosis in Hras5 tumor xenograft in athymic ratsCan DCEMRI assess the effect of green tea on the angiogenic properties of rodent prostate tumors?The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis.DCE-MRI detects early vascular response in breast tumor xenografts following anti-DR5 therapyCorrelation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation.Molecular magnetic resonance imaging of angiogenesis in vivo using polyvalent cyclic RGD-iron oxide microparticle conjugates.Functional magnetic resonance imaging for defining the biological target volumeHigh-field small animal magnetic resonance oncology studies.Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI.Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model.Early therapy evaluation of combined cetuximab and irinotecan in orthotopic pancreatic tumor xenografts by dynamic contrast-enhanced magnetic resonance imaging.Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments.Rapid vessel regression, protease inhibition, and stromal normalization upon short-term vascular endothelial growth factor receptor 2 inhibition in skin carcinoma heterotransplants.Dynamic gadobutrol-enhanced MRI predicts early response to antivascular but not to antiproliferation therapy in a mouse xenograft model.Multimodal imaging and computer assisted diagnosis for functional tumour characterisation.Identification of the S100 fused-type protein hornerin as a regulator of tumor vascularity.Multiparametric MR imaging of tumor response to intraarterial chemotherapy in orthotopic xenograft models of human metastatic brain tumor.Toxicity and biomedical imaging of layered nanohybrids in the mouse
P2860
Q26752752-4064ED68-79F9-4AEA-84A5-726D1931256BQ28389391-6CFFFBA8-1002-456F-B305-3FC3ECD3E5C7Q28389985-25926404-C5A4-4A20-B303-FB423B60D694Q28395095-E746D506-A97D-42DD-AB8B-A217815E6AFCQ30437998-E2445388-5604-479A-ACEB-8F8B3EDD3E54Q30447988-47E3AA6D-73F4-4F79-93B5-5AEF7EDE1496Q30687678-8DFC9AA0-05C3-405C-850C-71C790DAC3FFQ30822146-C77C82A0-5AE7-47ED-946F-87D2F4214BB0Q30992467-19A0576B-4A15-4EC7-8AFE-2083DEB2BBA4Q33286035-659A3551-6F4F-4AEB-9D4D-3A0D7B8AF3C4Q33489265-2366B845-D5BA-4D5C-9FD3-8F8A4122E423Q33823191-95EE53F2-4B07-4365-973F-2CDB0EF79A67Q34066039-52CDFBCE-C40A-406E-9C9B-76929D8BD8CFQ35068706-D1ECDC92-D0E0-451C-AAF5-156B3F0B3647Q35148491-C14871FE-4CEE-4C5D-824A-68B35A86EF27Q35214880-6CA7C3FA-30BA-4BA9-B2B7-45B79B23DF68Q35312455-0B07CF4B-502C-4560-B8B8-DB191CCB239AQ36640234-94E6914C-A24B-418C-86CE-ED9B3A67038CQ37417880-50052356-CB5B-4B0D-A61C-91F15730C1BCQ37642829-9462A337-589E-4D09-9AFB-514D4BDE0FD2Q38168371-5B7C246B-DD11-4E99-94F0-5CE0FB94A903Q38597593-25618532-DEBD-49BB-BE05-9C47C4575EC2Q39141313-1F88055A-A731-4C73-B9EF-9B60F5A9946BQ39974871-A2E0FA44-E6D9-4BCC-9D3E-BA7B7BA61B5CQ41701383-5F378CC2-FCEC-4FF1-B7B1-6372636949BCQ49022897-78D9DC73-57D8-41ED-B717-89D903286B67Q57186817-2D929B95-8035-4BBA-BD92-3C58E1AC33F6
P2860
Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Dynamic contrast-enhanced magn ...... eceptor 2 blockade with DC101.
@en
type
label
Dynamic contrast-enhanced magn ...... eceptor 2 blockade with DC101.
@en
prefLabel
Dynamic contrast-enhanced magn ...... eceptor 2 blockade with DC101.
@en
P2093
P2860
P356
P1433
P1476
Dynamic contrast-enhanced magn ...... eceptor 2 blockade with DC101.
@en
P2093
Dan W Miller
Fabian Kiessling
Margareta M Mueller
Martin Krix
Matthias P Lichy
Melanie Heilmann
Nabeel Farhan
Norbert E Fusenig
Peter Bohlen
Silvia Vosseler
P2860
P304
P356
10.1593/NEO.03394
P577
2004-05-01T00:00:00Z